Launch of Industrial Manufacturing of Chromatography Resins by Arg Biotech Company
We are excited to announce that Arg Biotech Company has officially launched the industrial manufacturing of chromatography resins for the purification of biological medicines since 2023. This significant Launch of Industrial Manufacturing advancement at allows us to produce up to 1,000 liters of high-quality chromatography resins per year, addressing the growing needs of the biopharmaceutical industry in Iran. In the industrial phase of Arg Biotech, the resins produced include: Argpure CM Sepharose, ArgPure DEAE Sepharose, ArgPure Q Sepharose, ArgPure SP Sepharose, ArgPure Ni-NTA Sepharose, ArgPure Capto Q Sepharose,ArgPure phenyl Sepharose, ArgPure Sepharose Cl-6B
Our commitment to innovation and quality ensures that these resins will facilitate the efficient purification processes required for the development and production of biological medicines. By establishing local manufacturing capabilities, we aim to enhance self-sufficiency in our country’s biotechnology sector and support the advancement of healthcare solutions
At Arg Biotech, we believe that this initiative will not only contribute to the local economy but also strengthen the foundation for future biopharmaceutical developments in Iran. We are dedicated to providing our partners and clients with the highest standards of products and services to meet their specific needs
.We look forward to the positive impact this launch will have on the industry and are excited about the opportunities it presents for collaboration and growth